Literature DB >> 9593031

Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens.

J I Cohen1.   

Abstract

In vitro assays indicate that both major histocompatibility complex (MHC) class I and II-restricted cytotoxic T lymphocytes are important for recognition of varicella-zoster virus (VZV)-infected cells. This study demonstrates that infection of human fibroblasts with wild-type or recombinant-derived strain Oka VZV results in down-regulation of surface expression of class I MHC heavy chains. Radioactive labeling of infected cells indicated that the amount of newly synthesized class I antigen was similar in uninfected and VZV-infected cells. In addition, immunoblotting showed that the amount of total cellular class I MHC heavy chains was unaffected by VZV infection. These results suggest that the reduction of class I heavy chains on the surface of VZV-infected cells is due to a defect in posttranslational processing. The down-regulation of class I MHC antigens in VZV-infected cells may provide a mechanism for the virus to escape the host immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593031     DOI: 10.1086/517821

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.

Authors:  J I Cohen; K Lekstrom
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Authors:  Danijela Koppers-Lalic; Eric A J Reits; Maaike E Ressing; Andrea D Lipinska; Rupert Abele; Joachim Koch; Marisa Marcondes Rezende; Pieter Admiraal; Daphne van Leeuwen; Krystyna Bienkowska-Szewczyk; Thomas C Mettenleiter; Frans A M Rijsewijk; Robert Tampé; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

3.  Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts.

Authors:  Dallas Jones; Anna Blackmon; C Preston Neff; Brent E Palmer; Don Gilden; Hussain Badani; Maria A Nagel
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 5.  Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases.

Authors:  Angela Erazo; Paul R Kinchington
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 7.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

8.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

9.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

10.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.